26864-56-2 | 1-[4,4-bis(4-fluorophenyl)butyl]-4-[4-chloro-3-(trifluoromethyl)phenyl]piperidin-4-ol

Packsize	Purity	Availability	Price	Discounted Price
200mg	98%	in stock	$18.00	$12.00
1g	98%	in stock	$63.00	$45.00
5g	98%	in stock	$231.00	$162.00
10g	98%	in stock	$385.00	$269.00
25g	98%	in stock	$738.00	$517.00
100g	98%	in stock	$1,878.00	$1,315.00

Description

• Catalog Number: AI46187
• Chemical Name: 1-[4,4-bis(4-fluorophenyl)butyl]-4-[4-chloro-3-(trifluoromethyl)phenyl]piperidin-4-ol
• CAS Number: 26864-56-2
• Molecular Formula: C28H27ClF5NO
• Molecular Weight: 523.9651
• MDL Number: MFCD00866714
• SMILES: Fc1ccc(cc1)C(c1ccc(cc1)F)CCCN1CCC(CC1)(O)c1ccc(c(c1)C(F)(F)F)Cl
• NSC Number: 759179

Computed Properties

• Complexity: 647
• Covalently-Bonded Unit Count: 1
• Heavy Atom Count: 36
• Hydrogen Bond Acceptor Count: 7
• Hydrogen Bond Donor Count: 1
• Rotatable Bond Count: 7
• XLogP3: 7.3

Literature

• Calcium-dependent inhibition of adrenal TREK-1 channels by angiotensin II and ionomycin.

  American journal of physiology. Cell physiology 20110901

• Clarithromycin, a cytochrome P450 inhibitor, can reverse mefloquine resistance in Plasmodium yoelii nigeriensis- infected Swiss mice.

  Parasitology 20110801

• Synthesis and SAR study of diphenylbutylpiperidines as cell autophagy inducers.

  Bioorganic & medicinal chemistry letters 20110101

• Identification of novel functional inhibitors of acid sphingomyelinase.

  PloS one 20110101

• Impaired cerebellar functional connectivity in schizophrenia patients and their healthy siblings.

  Frontiers in psychiatry 20110101

• The position of mefloquine as a 21st century malaria chemoprophylaxis.

  Malaria journal 20100101

• An overview of Indian research in schizophrenia.

  Indian journal of psychiatry 20100101

• Research on antipsychotics in India.

  Indian journal of psychiatry 20100101

• Antipsychotics and risk of venous thromboembolism: A population-based case-control study.

  Clinical epidemiology 20090101

• Identification of new functional inhibitors of acid sphingomyelinase using a structure-property-activity relation model.

  Journal of medicinal chemistry 20080124

• Tourette's syndrome: clinical features, pathophysiology, and therapeutic approaches.

  Dialogues in clinical neuroscience 20070601

• Efficacy of typical and atypical antipsychotics for primary and comorbid anxiety symptoms or disorders: a review.

  The Journal of clinical psychiatry 20060901

• Penfluridol for schizophrenia.

  The Cochrane database of systematic reviews 20060419

• Brief psychotic disorder associated with Sturge-Weber syndrome.

  European psychiatry : the journal of the Association of European Psychiatrists 20050601

• Safety of haloperidol and penfluridol in pregnancy: a multicenter, prospective, controlled study.

  The Journal of clinical psychiatry 20050301

• An ACTH- and ATP-regulated background K+ channel in adrenocortical cells is TREK-1.

  The Journal of biological chemistry 20021220

• Differential inhibition of T-type calcium channels by neuroleptics.

  The Journal of neuroscience : the official journal of the Society for Neuroscience 20020115

• LC-MS-MS analysis of the neuroleptics clozapine, flupentixol, haloperidol, penfluridol, thioridazine, and zuclopenthixol in hair obtained from psychiatric patients.

  Journal of analytical toxicology 20020101

• Comparative short-term evaluation of penfluridol and trifluoperazine in chronic schizophrenia.

  Indian journal of physiology and pharmacology 19880101

• [Pharmacological studies of antipsychotic drug, penfluridol. 2. General pharmacological properties].

  Nihon yakurigaku zasshi. Folia pharmacologica Japonica 19760701